Standard Life Aberdeen Earnings Calls
| Release date | Mar 04, 2026 |
| EPS estimate | $0.0996 |
| EPS actual | $0.0965 |
| EPS Surprise | -3.14% |
| Revenue estimate | 860.309M |
| Revenue actual | 856.653M |
| Revenue Surprise | -0.425% |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.0892 |
| EPS actual | $0.185 |
| EPS Surprise | 107.07% |
| Revenue estimate | 922.2M |
| Revenue actual | 895.307M |
| Revenue Surprise | -2.92% |
| Release date | Aug 04, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Mar 04, 2025 |
| EPS estimate | $0.0799 |
| EPS actual | $0.0571 |
| EPS Surprise | -28.57% |
| Revenue estimate | 866.094M |
| Revenue actual | 1.037B |
| Revenue Surprise | 19.75% |
Last 4 Quarters for Standard Life Aberdeen
Below you can see how SLFPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 04, 2025 |
| Price on release | $2.05 |
| EPS estimate | $0.0799 |
| EPS actual | $0.0571 |
| EPS surprise | -28.57% |
| Date | Price |
|---|---|
| Feb 26, 2025 | $2.01 |
| Feb 27, 2025 | $2.01 |
| Feb 28, 2025 | $2.05 |
| Mar 03, 2025 | $2.05 |
| Mar 04, 2025 | $2.05 |
| Mar 05, 2025 | $2.05 |
| Mar 06, 2025 | $2.05 |
| Mar 07, 2025 | $2.27 |
| Mar 10, 2025 | $2.27 |
| 4 days before | 1.99% |
| 4 days after | 10.73% |
| On release day | 0% |
| Change in period | 12.94% |
| Release date | Aug 04, 2025 |
| Price on release | $2.60 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 29, 2025 | $2.55 |
| Jul 30, 2025 | $2.55 |
| Jul 31, 2025 | $2.65 |
| Aug 01, 2025 | $2.65 |
| Aug 04, 2025 | $2.60 |
| Aug 05, 2025 | $2.60 |
| Aug 06, 2025 | $2.60 |
| Aug 07, 2025 | $2.72 |
| Aug 08, 2025 | $2.55 |
| 4 days before | 1.96% |
| 4 days after | -1.92% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jul 30, 2025 |
| Price on release | $2.55 |
| EPS estimate | $0.0892 |
| EPS actual | $0.185 |
| EPS surprise | 107.07% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $2.55 |
| Jul 25, 2025 | $2.57 |
| Jul 28, 2025 | $2.55 |
| Jul 29, 2025 | $2.55 |
| Jul 30, 2025 | $2.55 |
| Jul 31, 2025 | $2.65 |
| Aug 01, 2025 | $2.65 |
| Aug 04, 2025 | $2.60 |
| Aug 05, 2025 | $2.60 |
| 4 days before | 0% |
| 4 days after | 1.96% |
| On release day | 3.92% |
| Change in period | 1.96% |
| Release date | Mar 04, 2026 |
| Price on release | $2.85 |
| EPS estimate | $0.0996 |
| EPS actual | $0.0965 |
| EPS surprise | -3.14% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $2.79 |
| Feb 27, 2026 | $2.79 |
| Mar 02, 2026 | $2.85 |
| Mar 03, 2026 | $2.85 |
| Mar 04, 2026 | $2.85 |
| Mar 05, 2026 | $2.85 |
| Mar 06, 2026 | $2.85 |
| Mar 09, 2026 | $2.85 |
| Mar 10, 2026 | $2.85 |
| 4 days before | 2.15% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 2.15% |
Standard Life Aberdeen Earnings Call Transcript Summary of Q4 2025
Aberdeen reported steady progress in 2025 with group adjusted operating profit up 4% to GBP 264m and IFRS profit before tax up 76% to GBP 442m (driven largely by a revaluation of its strategic investment). Interactive investor (ii) delivered an exceptional year: customers +14% to 0.5m, net inflows +28% to GBP 7.3bn, revenue +19% to GBP 330m and ii adjusted operating profit +34% to GBP 155m, becoming the largest contributor to group profits. Adviser experienced weaker profitability after strategic repricing (revenue -14%) but materially improved net outflows (almost halved year-on-year) and service metrics; the business targets net positive flows in 2026 and GBP 1bn of net flows deferred to 2027. Investments showed improving flows and performance (3‑year outperformance 80%), a 5% increase in adjusted operating profit to GBP 64m, and notable mandate wins including the Stagecoach pension agreement (~GBP 1.2bn AUM). The transformation programme exceeded expectations, delivering GBP 180m of annualized savings and reducing group expenses by 5%; circa GBP 30m of residual annualized benefit is expected to flow through in 2026. Capital position strengthened after moving to an internal capital assessment: regulatory requirement down 17% to GBP 879m, CET coverage 163%, total coverage 218%; target operating range 140%–180% over the medium term. Dividend maintained at 14.6p per share. Guidance/targets: remain committed to 2026 group targets (adjusted operating profit at least GBP 300m and net capital generation around GBP 300m) and target net capital generation growth of 5%–10% p.a. thereafter (absent major market shocks). Management will prioritize paying down debt, invest selectively (including tech and AI), and continue to scale ii while returning Adviser to growth and further repositioning Investments.
Sign In
Buy SLFPF